NCT03836326

Brief Summary

Advances in medical technologies over the last three decades have increased survival rates in infants born preterm . Preterm infants are at high risk of developing developmental delays. Implementation of effective strategies aimed at improving the developmental outcome of preterm born children is critical. The proposed study is designed to evaluate the addition of a parent administered sensorimotor program on the developmental outcome of infants who are born preterm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 11, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

July 1, 2019

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2024

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

4.8 years

First QC Date

February 6, 2019

Last Update Submit

May 28, 2024

Conditions

Keywords

PrematurityDevelopmentParental engagementParental satisfaction

Outcome Measures

Primary Outcomes (1)

  • Attainment of independent oral feeds

    Number of days to transition from complete tube to complete oral feeds.

    3 years

Secondary Outcomes (4)

  • Weight gain

    3 years

  • Length of hospital stay

    3 years

  • Test of infant motor performance

    3 years

  • Acute stress of parents

    3 years

Study Arms (2)

Sensorimotor intervention

EXPERIMENTAL

Is a 15-minute intervention consisting of tactile (i.e., stroking the whole body) and oral input (i.e., stroking the oral structures) for 15 minutes duration. The program will start 24 hours after nasal continuous positive airway pressure (NCPAP) is discontinued and 24 hours after 80 ml/kg/day of enteral feeds are tolerated. The program will be administered once a day for 10 days, within a 14-day period. The parents will perform all the interventions in the NICU. The infants will remain in the isolette for the duration of the program. This intervention does not involve any drugs or medical procedures. It is an intervention commonly used by occupational and physical therapists in the neonatal intensive care unit.

Other: Sensorimotor interventionOther: Story telling attention refocusing intervention

Control

OTHER

Infants in the control group will receive standard care only.

Other: Control

Interventions

Sensorimotor intervention involves, stroking of the whole body including the oral structures, trunk and limbs. This intervention does not involve any drugs or medical procedure.

Also known as: Supplemental stimulation, Sensory input, Tactile input, Oral input
Sensorimotor intervention
ControlOTHER

Routine care provided by health professionals in the NICU

Control

A contact-free intervention where parents share stories with their infant for 10 minutes 3 times per week.

Also known as: STAR
Sensorimotor intervention

Eligibility Criteria

AgeUp to 34 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infants born \< 34 weeks gestation
  • Infants whose parent (s) intend on visiting regularly (\> 5 days)

You may not qualify if:

  • Infants born with a metabolic disorder or congenital abnormality
  • Infants whose parents are unable to participate due to cognitive, physical or social issues.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kingston Health Sciences Center

Kingston, Ontario, k7l2v7, Canada

Location

MeSH Terms

Conditions

Premature BirthLearning Disabilities

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Study Officials

  • Sandra Fucile, PhD

    Queen's University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
A prospective randomized block clinical trial will be conducted. Infants will be randomized into experimental (PASI program) and control (standard care program) groups using a block size of four per arm, where the first set of four participants will be in the experimental group and once they have completed the intervention, the subsequent set of four participants will be in the control group. A randomized block design was selected because the treatment assignment cannot be masked. The block randomization procedure will reduce the potential for contamination between groups.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Randomized clinical trail
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

February 6, 2019

First Posted

February 11, 2019

Study Start

July 1, 2019

Primary Completion

May 1, 2024

Study Completion

May 1, 2024

Last Updated

May 30, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations